| Financial Year |
March 31 2023 |
| Monetary Funds |
847,370,219.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
437,204,616.56 |
| Accounts Receivable |
1,527,240,229.90 |
| Advances to Suppliers |
18,588,890.72 |
| Other Receivables |
98,748,236.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,308,062,197.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
253,854,732.54 |
| Total Current Assets |
4,567,393,164.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,022,317.56 |
| Investment Properties |
15,491,027.24 |
| Fixed Assetes |
2,013,231,286.39 |
| Under-construction Projects |
209,679,111.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
183,217,385.07 |
| R&D expenses |
-- |
| Goodwill |
34,010,305.35 |
| Long-Term Deferred and Prepaid Expenses |
20,771,747.37 |
| Deferred Income Tax Assets |
72,490,549.97 |
| Other Non-Current Assets |
238,346,276.81 |
| Sub-Total of Non-Current Assets |
2,932,557,198.49 |
| Total Assets |
7,499,950,362.76 |
| Short-Term Loans |
432,216,422.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
873,969.15 |
| Accounts Payable |
362,502,904.94 |
| Accounts Received In Advance |
31,731.75 |
| Employee Compensation Payable |
20,247,831.83 |
| Taxes Payable |
53,194,700.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,570,992.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,121,160.31 |
| Other Current Liabilities |
225,679.45 |
| Sub-Total of Current Liabilities |
946,004,954.72 |
| Long-term Loans |
362,611,702.78 |
| Bonds Payable |
383,445,509.31 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
51,096,810.91 |
| Other Non-Current Liabilities |
1,353,012.50 |
| Sub-Total of Non-Current Liabilities |
967,095,101.99 |
| Total Liabilities |
1,913,100,056.71 |
| Paid-In Capital(Or Share Stock) |
459,296,479.00 |
| Capital Surplus |
1,293,779,782.77 |
| Surplus Reserve |
313,351,964.78 |
| LESS:Treasury Stock |
64,985,984.25 |
| Undistributed Profits |
3,310,999,816.93 |
| Minority Stockholder's Interest |
185,095,175.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,401,755,130.28 |
| Owner's Equity（Stockholder's Equity） |
5,586,850,306.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,499,950,362.76 |
